• If this is your first visit, be sure to check out the FAQ & read the forum rules. To view all forums, post or create a new thread, you must be an AAPC Member. If you are a member and have already registered for member area and forum access, you can log in by clicking here. If you've forgotten your username or password use our password reminder tool. To start viewing messages, select the forum that you want to visit from the selection below..
  • Important Note: We will be performing a scheduled maintenance on 30th Nov, 2021. The site will be offline from 8:30PM (MT) till 10:30 PM MT. We apologize for any inconvenience this may cause.

Question Hx of Breast CA pt, with Osteopenia no longer on Aromatase Inhibitor

emonet01

New
Messages
6
Best answers
0
I am reaching out today on behalf of our coding team looking for some advice...

We have been struggling with coding Zometa for Osteopenia lately. One of our struggles are the pt's that have a Hx of Breast CA, they have Osteopenia, but they either are no longer on an Aromatase Inhibitor, they are on Tamoxifen (Z79.810) OR they never received treatment from with an AI. The CMS Article for Zometa states that in order to report M85.80 for Osteopenia, you have to also code Z79.811 and Z85.3. If the pt is no longer on the AI, then are we correct in our thought that we are no longer reporting the Z79.811 since that is no longer an active medication. Medicare does not seem to like it when we just code the Osteopenia or the Osteopenia with the Hx of Breast CA.

I would love to hear the thoughts of other coders. Thanks!
 

rachaelwilleford

Guru
Local Chapter Officer
Messages
107
Location
Carencro, LA
Best answers
0
I am reaching out today on behalf of our coding team looking for some advice...

We have been struggling with coding Zometa for Osteopenia lately. One of our struggles are the pt's that have a Hx of Breast CA, they have Osteopenia, but they either are no longer on an Aromatase Inhibitor, they are on Tamoxifen (Z79.810) OR they never received treatment from with an AI. The CMS Article for Zometa states that in order to report M85.80 for Osteopenia, you have to also code Z79.811 and Z85.3. If the pt is no longer on the AI, then are we correct in our thought that we are no longer reporting the Z79.811 since that is no longer an active medication. Medicare does not seem to like it when we just code the Osteopenia or the Osteopenia with the Hx of Breast CA.

I would love to hear the thoughts of other coders. Thanks!
They don't like it because it's not indicated if the patient is no longer on an aromatase inhibitor. Indications are osteoporosis (with multiple causes), prevention in bone loss in prostate cancer, and prevention in bone loss in women with breast cancer on aromatase inhibitor treatment. Patients who are being treated for osteoporosis can still receive once they are osteopenic because 1) you can establish the osteoporosis that has improved with treatment and 2) once you take the treatment away, studies have shown that the patient's bone density will worsen. This isn't so with the breast related. (As explained to me by one of our oncologists and the pharm rep)
 
Top